rxstat › Shortages › Mixed Salts Amphetamine
Mixed Salts Amphetamine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Mixed Salts Amphetamine products are in shortage in Canada (3 of 25 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jun 19, 2026.
In shortage since
May 19, 2026
Est. full return
Jun 19, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-AMPHETAMINE XR
25MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02445530 · since May 19, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-AMPHETAMINE XR
15MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02445514 · since May 19, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
Active shortageAPO-AMPHETAMINE XR
10MG · CAPSULE (EXTENDED RELEASE) · APOTEX INC
DIN 02445506 · since May 26, 2026, est. end Jun 19, 2026 · Disruption of the manufacture of the drug.
DiscontinuedTEVA-AMPHETAMINE XR
5MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439239
DiscontinuedTEVA-AMPHETAMINE XR
30MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439298
DiscontinuedTEVA-AMPHETAMINE XR
25MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439271
DiscontinuedTEVA-AMPHETAMINE XR
20MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439263
DiscontinuedTEVA-AMPHETAMINE XR
15MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439255
DiscontinuedTEVA-AMPHETAMINE XR
10MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439247
ResolvedTEVA-AMPHETAMINE XR
10MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439247 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-AMPHETAMINE XR
5MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439239 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-AMPHETAMINE XR
30MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02439298 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Mixed Salts Amphetamine is currently affected by 3 active shortage reports filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Mixed Salts Amphetamine is classified under “PSYCHOSTIMULANTS AND NOOTROPICS” (ATC N06BA).
Recent changes
Common questions
When will Mixed Salts Amphetamine be back in stock in Canada?
The latest manufacturer estimate is Jun 19, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Mixed Salts Amphetamine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.